A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens
Summary: At its current rate, the rise of antimicrobial-resistant (AMR) infections is predicted to paralyze our industries and healthcare facilities while becoming the leading global cause of loss of human life. With limited new antibiotics on the horizon, we need to invest in alternative solutions....
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-04-01
|
| Series: | iScience |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222003911 |
| _version_ | 1819026016156254208 |
|---|---|
| author | Vivek K. Mutalik Adam P. Arkin |
| author_facet | Vivek K. Mutalik Adam P. Arkin |
| author_sort | Vivek K. Mutalik |
| collection | DOAJ |
| description | Summary: At its current rate, the rise of antimicrobial-resistant (AMR) infections is predicted to paralyze our industries and healthcare facilities while becoming the leading global cause of loss of human life. With limited new antibiotics on the horizon, we need to invest in alternative solutions. Bacteriophages (phages)—viruses targeting bacteria—offer a powerful alternative approach to tackle bacterial infections. Despite recent advances in using phages to treat recalcitrant AMR infections, the field lacks systematic development of phage therapies scalable to different applications. We propose a Phage Foundry framework to establish metrics for phage characterization and to fill the knowledge and technological gaps in phage therapeutics. Coordinated investment in AMR surveillance, sampling, characterization, and data sharing procedures will enable rational exploitation of phages for treatments. A fully realized Phage Foundry will enhance the sharing of knowledge, technology, and viral reagents in an equitable manner and will accelerate the biobased economy. |
| first_indexed | 2024-12-21T05:19:52Z |
| format | Article |
| id | doaj.art-0b5d873c9b964a32a1d9e954e775f9ac |
| institution | Directory Open Access Journal |
| issn | 2589-0042 |
| language | English |
| last_indexed | 2024-12-21T05:19:52Z |
| publishDate | 2022-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | iScience |
| spelling | doaj.art-0b5d873c9b964a32a1d9e954e775f9ac2022-12-21T19:14:49ZengElsevieriScience2589-00422022-04-01254104121A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial PathogensVivek K. Mutalik0Adam P. Arkin1Innovative Genomics Institute, University of California, Berkeley, CA, USA; Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA; Corresponding authorInnovative Genomics Institute, University of California, Berkeley, CA, USA; Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA; Department of Bioengineering, University of California, Berkeley, CA, USA; Corresponding authorSummary: At its current rate, the rise of antimicrobial-resistant (AMR) infections is predicted to paralyze our industries and healthcare facilities while becoming the leading global cause of loss of human life. With limited new antibiotics on the horizon, we need to invest in alternative solutions. Bacteriophages (phages)—viruses targeting bacteria—offer a powerful alternative approach to tackle bacterial infections. Despite recent advances in using phages to treat recalcitrant AMR infections, the field lacks systematic development of phage therapies scalable to different applications. We propose a Phage Foundry framework to establish metrics for phage characterization and to fill the knowledge and technological gaps in phage therapeutics. Coordinated investment in AMR surveillance, sampling, characterization, and data sharing procedures will enable rational exploitation of phages for treatments. A fully realized Phage Foundry will enhance the sharing of knowledge, technology, and viral reagents in an equitable manner and will accelerate the biobased economy.http://www.sciencedirect.com/science/article/pii/S2589004222003911MicrobiologyBiotechnologyBiotechnology regulationSynthetic biology |
| spellingShingle | Vivek K. Mutalik Adam P. Arkin A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens iScience Microbiology Biotechnology Biotechnology regulation Synthetic biology |
| title | A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens |
| title_full | A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens |
| title_fullStr | A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens |
| title_full_unstemmed | A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens |
| title_short | A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens |
| title_sort | phage foundry framework to systematically develop viral countermeasures to combat antibiotic resistant bacterial pathogens |
| topic | Microbiology Biotechnology Biotechnology regulation Synthetic biology |
| url | http://www.sciencedirect.com/science/article/pii/S2589004222003911 |
| work_keys_str_mv | AT vivekkmutalik aphagefoundryframeworktosystematicallydevelopviralcountermeasurestocombatantibioticresistantbacterialpathogens AT adamparkin aphagefoundryframeworktosystematicallydevelopviralcountermeasurestocombatantibioticresistantbacterialpathogens AT vivekkmutalik phagefoundryframeworktosystematicallydevelopviralcountermeasurestocombatantibioticresistantbacterialpathogens AT adamparkin phagefoundryframeworktosystematicallydevelopviralcountermeasurestocombatantibioticresistantbacterialpathogens |